JJ Open Meeting: October 10, 2022
Open Meeting Notification — Proposed LCD(s) Released for Comment
A/B MAC LCDs
- Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound DL39128/DA58883
- Luteinizing Hormone-Releasing Hormone (LHRH) Analogs DL39387/DA59160
- Magnesium DL39400/DA59186
- Near-Infrared Spectroscopy in Wound and Flap Management DL39385/A59158
- Sacroiliac Joint Injections and Procedures DL39402/DA59192
- Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain DL39420/DA59205
- Transurethral Waterjet Ablation of the Prostate DL38549/DA58008
- Vitamin D Assay Testing DL39391/DA59170
- White Cell Colony Stimulating Factors DL37176/DA56748
The Centers for Medicare & Medicaid Services (CMS) assigned Palmetto GBA the task of developing local coverage determinations (LCDs) for processing and reviewing Medicare claims for Jurisdictions J and M. These LCDs can be found utilizing the Proposed LCD by Contractor Report on the Medicare Coverage Database. The entire LCD and related billing and coding article should be completely reviewed prior to the preparation of comments. A link to the proposed billing and coding article is located under the Associated Documents section of the proposed LCD.
Palmetto GBA is soliciting comments on these proposed LCDs from physicians, manufacturers, suppliers and other professionals involved in the ordering and/or provisioning of these items. Other stakeholder comments are also welcomed. For medical professionals, we ask that you distribute these proposed LCDs to selected members of your organization for review and comment. If you disagree with any aspect of an LCD, you should be very specific in your comment and, if possible, offer an alternative. You should provide a clinical rationale for your position, including references from published clinical literature (e.g., peer-reviewed journals, clinical society guidelines, etc.). Submission of full-text literature supporting your position is strongly encouraged. We ask for a written response, regardless of your agreement or disagreement.
Please submit your comments electronically to Palmetto GBA at A.Policy@palmettogba.com or B.Policy@PalmettoGBA.com no later than October 15, 2022.
Meeting Information
An open meeting will be held via web conference. This meeting will be recorded and will be published on the Palmetto GBA website. Interested parties from within the jurisdiction may attend this open meeting. This meeting is for oral presentations only. Palmetto GBA requires all presenters at the open meeting to also submit their oral comments through the formal comment process.
Meeting Title: Palmetto GBA Open Meeting
Meeting Date: October 10, 2022
Meeting Time: Jurisdiction J (JJ) 1:30 – 1:45 p.m. ET
Join Online Here: Jurisdiction J
Meeting Dial-In Number: (803) 393–7908
Meeting ID/Access Code: 528 407 424#
The JJ Open Meeting Agenda (PDF) is now available.
Important reminder: Providers and/or suppliers are cautioned not to make any changes based upon the information contained in a proposed LCD. Proposed LCDs are often substantially revised based upon the comments received. Revisions will be considered once all comments have been reviewed. The final LCD will be published in the CMS Medicare Coverage Database and on individual contractors’ websites, allowing for a minimum of 45-days’ public notice before the LCD becomes effective.
Refer to each contractor’s web site for additional information about LCD development and for copies of the draft LCDs.
Meeting Documents
- Open Meeting Agenda
- Open Meeting Transcript
- Meeting Video Recording